Anshul Innovative Chemistry Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 43.81 Cr
as on 16-11-2024
- Revenue 720.73%
(FY 2023)
- Profit -22629.27%
(FY 2023)
- Ebitda -1548.46%
(FY 2023)
- Net Worth -162.67%
(FY 2023)
- Total Assets 62.89%
(FY 2023)
About Anshul Innovative Chemistry
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹43.81 Cr.
Ravi Shroff, Hrishit Shroff, and Shirish Satpute serve as directors at the Company.
- CIN/LLPIN
U24290MH2020PTC336416
- Company No.
336416
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Anshul Innovative Chemistry?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Shroff  | Director | 22-Jan-2020 | Current |
| Hrishit Shroff | Director | 22-Jan-2020 | Current |
| Shirish Satpute | Director | 06-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Anshul Innovative Chemistry.
Anshul Innovative Chemistry Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 720.73% increase. The company also saw a substantial fall in profitability, with a 22629.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 162.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anshul Innovative Chemistry?
In 2022, Anshul Innovative Chemistry had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excel Bio Resources Limited
Active 16 years 11 monthsRavi Shroff and Hrishit Shroff are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Jul 2021 | ₹43.81 Cr | Open |
How Many Employees Work at Anshul Innovative Chemistry?
Anshul Innovative Chemistry has a workforce of 49 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anshul Innovative Chemistry, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anshul Innovative Chemistry's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
